QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 nexalin-technology-has-received-a-notice-of-allowance-for-its-us-patent-application-18342590-titled-transcranial-alternating-current-dynamic-frequency-stimulation-tacs-method-for-alzheimers-and-dementia

https://patentcenter.uspto.gov/applications/18342590/ifw/docs

 nexalin-technology-regains-compliance-with-nasdaq-continued-listing-requirements

Nexalin Technology, Inc. (the "Company" or "Nexalin") (NASDAQ:NXL, NXLIW))) announced that the Company received...

 why-skillsoft-shares-are-trading-lower-by-around-27-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter...

 nexalin-technology-ceo-provides-letter-to-shareholders

To our valued shareholders,I want to take this opportunity to express my sincere gratitude for your continued trust and investm...

 nexalin-technology-awarded-key-patent-related-to-gen-3-halo-clarity

Mark White, CEO of Nexalin Technology, stated, "This method of use patent award marks a major achievement for the Company a...

 why-stryve-foods-shares-are-trading-lower-by-around-25-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss.

 nexalin-technology-granted-us-patent-11944806-transcranial-alternating-current-dynamic-frequency-stimulation-method-for-anxiety-depression-and-insomnia

https://ppubs.uspto.gov/dirsearch-public/print/downloadPdf/11944806

 nexalin-technology-announces-results-of-clinical-study-validating-its-gen-2-tacs-device-for-reducing-pain-among-veterans-with-mild-traumatic-brain-injury-at-university-of-california-san-diego

Collaborative Study involving the VA and UCSD achieved statistically significant decrease in PCS and PTSD symptoms versus contr...

 nexalin-technology-commences-sales-of-gen-2-neurostimulation-device-to-new-mental-health-center-in-oman-dedicated-to-nexalins-technology

Nexalin Technology, Inc. (the "Company" or "Nexalin") (NASDAQ:NXL, NXLIW)))) today announced that it has commen...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION